Tapia González Irati, Esteve Simó Vicent, Moreno Guzman Fátima, Fulquet Nicolás Miquel, Duarte Gallego Verónica, Saurina Solé Anna, Pou Potau Mónica, Ramírez de Arellano Serna Manel
1 Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
2 Department of Nephrology, Hospital de Terrassa, Consorci Sanitari de Terrassa, Barcelona, Spain.
J Vasc Access. 2019 Jul;20(4):386-391. doi: 10.1177/1129729818809013. Epub 2018 Nov 16.
Vascular access is essential to perform an adequate hemodialysis. Needle cannulation in vascular access is usually painful. There is little scientific evidence on the analgesic effect of thermotherapy. The aim of this study was to evaluate the analgesic effect of thermotherapy on vascular access cannulation.
We performed a 2-week single center prospective study. Demographic data and vascular access location were collected. The main outcome was pain perceived in vascular access cannulation measured by the visual analog scale. We performed two phases of study: phase I was performed with usual cannulation procedure, and in phase II, we applied local thermotherapy for 15 min (hot packs: 60 s, 600 W). Also, main hemodynamic data, local, and vascular access-related complications were recorded.
A total of 34 patients were enrolled, with a mean age of 67.3 ± 16.4 years and 49.1 ± 66.3 months on hemodialysis. Main cardiovascular risk factors are hypertension (81.8%) and diabetes mellitus (39.4%). Most common vascular access is left radiocephalic fistula (45.5%). Mean weekly/patient cannulation is 6.03 ± 0.2. Mean visual analog scale is 3.8 ± 2.4. At the end of the study, thermotherapy on the vascular access revealed a significant decrease in visual analog scale (3.9 ± 2.4 vs 2.6 ± 2.0, p = 0.002), without hemodynamic changes pre- and post-intervention, nor changes in analgesic or antihypertensive treatment. One patient had a mild surface erythema. No further complications related to vascular access were observed.
(1) Thermotherapy on the vascular access reduced the pain caused by needle cannulation in our patients, without complications related to vascular access. (2) We will consider its clinical application in those painful vascular access cannulations at our hemodialysis unit. (3) Further studies are required to assess other potential beneficial effects added to thermotherapy in vascular access cannulation procedure.
血管通路对于充分进行血液透析至关重要。血管通路的穿刺通常会引起疼痛。关于热疗法镇痛效果的科学证据很少。本研究的目的是评估热疗法对血管通路穿刺的镇痛效果。
我们进行了一项为期2周的单中心前瞻性研究。收集了人口统计学数据和血管通路位置。主要结局是通过视觉模拟量表测量的血管通路穿刺时的疼痛程度。我们进行了两个研究阶段:第一阶段采用常规穿刺程序,在第二阶段,我们应用局部热疗法15分钟(热敷:60秒,600瓦)。此外,记录了主要血流动力学数据、局部和血管通路相关并发症。
共纳入34例患者,平均年龄67.3±16.4岁,血液透析时间49.1±66.3个月。主要心血管危险因素为高血压(81.8%)和糖尿病(39.4%)。最常见的血管通路是左桡动脉头静脉内瘘(45.5%)。每位患者平均每周穿刺6.03±0.2次。视觉模拟量表平均评分为3.8±2.4。研究结束时,对血管通路进行热疗法后,视觉模拟量表评分显著降低(3.9±2.4对2.6±2.0,p=0.002),干预前后血流动力学无变化,镇痛或降压治疗也无变化。1例患者出现轻度表面红斑。未观察到与血管通路相关的其他并发症。
(1)对血管通路进行热疗法可减轻患者穿刺时的疼痛,且无血管通路相关并发症。(2)我们将考虑在我们的血液透析单元将其应用于那些疼痛的血管通路穿刺。(3)需要进一步研究以评估热疗法在血管通路穿刺过程中的其他潜在有益作用。